CIK: 1240014 - Address: C/O Sutro Biopharma, Inc., 111 Oyster Point Blvd., South San Francisco, CA 94080
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/7/24 16:21
3/5/24
STROSutro Biopharma, Inc.HealthBioPrdBiological Products, (No DiagAlbini Edward CCAOCFO,SecrM.d00.00099107D
3/6/24 16:18
3/4/24
STROSutro Biopharma, Inc.HealthBioPrdBiological Products, (No DiagAlbini Edward CCAOCFO,SecrM.d00.000910101D
3/5/24 16:29
3/1/24
STROSutro Biopharma, Inc.HealthBioPrdBiological Products, (No DiagAlbini Edward CCAOCFO,SecrM.d00.0008995D
1/31/24 16:28
1/29/24
STROSutro Biopharma, Inc.HealthBioPrdBiological Products, (No DiagAlbini Edward CCAOCFO,SecrM.d00.0005691D
3/7/23 16:22
3/3/23
STROSutro Biopharma, Inc.HealthBioPrdBiological Products, (No DiagAlbini Edward CCAOCFO,SecrM.d00.000182688D
2/14/23 17:12
2/13/23
STROSutro Biopharma, Inc.HealthBioPrdBiological Products, (No DiagAlbini Edward CCAOCFO,SecrM.d2655.8104614976D
1/31/23 17:19
1/27/23
STROSutro Biopharma, Inc.HealthBioPrdBiological Products, (No DiagAlbini Edward CCAOCFO,SecrM.d00.00052131D
3/7/22 19:09
3/5/22
STROSutro Biopharma, Inc.HealthBioPrdBiological Products, (No DiagAlbini Edward CCAOCFO,SecrM.d00.00094628D
2/1/22 20:31
1/29/22
STROSutro Biopharma, Inc.HealthBioPrdBiological Products, (No DiagAlbini Edward CCAOCFO,SecrM.d00.00053122D
9/28/21 18:53
9/24/21
STROSutro Biopharma, Inc.HealthBioPrdBiological Products, (No DiagAlbini Edward CCAOCFO,SecrM.d00.00076119D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact